Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Dec
11
2023
The March on Pharmaceutical Patents? Sheppard, Mullin, Richter & Hampton LLP
Dec
8
2023
EC Committee Begins Public Consultation on Its Preliminary Opinion for Titanium Dioxide Bergeson & Campbell, P.C.
Dec
8
2023
FDA Approves Two Gene Therapies to Treat Sickle Cell Disease Including a CRISPR-Based Therapy Foley & Lardner LLP
Dec
8
2023
McDermottPlus Check-Up: December 8, 2023 McDermott Will & Emery
Dec
8
2023
China on the Move: Fine-Tuning the Life Sciences Regulatory and Compliance Landscape Greenberg Traurig, LLP
Dec
8
2023
Prolific Plaintiff’s Lawyer Held in Contempt Keller and Heckman LLP
Dec
8
2023
Hospital Executive and Three Physicians to Pay More Than $880,000 to Resolve Kickback Allegations ArentFox Schiff LLP
Dec
8
2023
Illinois Supreme Court: Finger-Scan Information Collected by Healthcare Providers to Access Medications Is Exempt From BIPA Liability McDermott Will & Emery
Dec
7
2023
Win for Healthcare Institutions: Illinois High Court Rules Healthcare Employees’ Biometrics Exempt from BIPA Requirements Squire Patton Boggs (US) LLP
Dec
7
2023
Total Wine Tests the Boundaries of FTC CIDs McDermott Will & Emery
Dec
7
2023
Missouri Bill Proposed to Preempt California’s Proposition 12 Keller and Heckman LLP
Dec
6
2023
White House OSTP and NNCO Announce Series of Events in Celebration of 20th Anniversary of the Authorization of the NNI Bergeson & Campbell, P.C.
Dec
6
2023
Decentralized Clinical Trials: Diversity in Clinical Trials Foley & Lardner LLP
Dec
6
2023
This Week in 340B: November 28 – December 5, 2023 McDermott Will & Emery
Dec
6
2023
FDA’s Final Rule on Direct-to-Consumer Advertising – Presentation of Risk Information Foley & Lardner LLP
Dec
6
2023
Ten Highlights from the Environmental and Energy Space in 2023 ArentFox Schiff LLP
Dec
5
2023
Council On Supply Chain Resilience Tasked With Strengthening Domestic Supply Chains And Limiting Reliance On Foreign Medical Supplies Squire Patton Boggs (US) LLP
Dec
5
2023
Episode 30: Let’s Talk Compliance: Medical Device and Physician Arrangements [Podcast] Foley & Lardner LLP
Dec
5
2023
FDA Study Finds Biosimilars Are Interchangeable ArentFox Schiff LLP
Dec
5
2023
Proposed Amendments to the Proposition 65 Regulatory Landscape – Changes to Clear and Reasonable Warnings and Safe Harbor Methods under Article 6 Foley & Lardner LLP
Dec
5
2023
Unpacking Averages: Analyzing FDA Device-Related Citizens Petitions by Topic Epstein Becker & Green, P.C.
Dec
5
2023
USDA-AMS Updates List of Bioengineered Foods Keller and Heckman LLP
Dec
5
2023
Biden Administration Prioritizing Domestic Production of Pharmaceuticals . . . Again? Blank Rome LLP
Dec
4
2023
Report Spotlights Legal Risks of Biodiversity Loss in Agricultural, Seafood Industries Cadwalader, Wickersham & Taft LLP
Dec
4
2023
laAPHIS Announces Determination of Nonregulated Status for Insect-Resistant and Herbicide-Tolerant Maize Bergeson & Campbell, P.C.
Dec
4
2023
Spirited Decisions: How Governor Murphy’s Veto Shakes and Stirs New Jersey’s Liquor Laws Norris McLaughlin P.A.
Dec
4
2023
Brussels Regulatory Brief: November 2023 K&L Gates
Dec
4
2023
Third Time a Charm for Alabama Medical Cannabis Awards? Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins